News & Updates

Show Multimedia Only

ILD ups risks of pneumonitis, mortality in patients taking ICIs

14 Apr 2026

Among patients receiving immune checkpoint inhibitors (ICIs), those with interstitial lung disease (ILD) have a significantly greater risk of developing checkpoint inhibitor pneumonitis (CIP) and may experience worse outcomes, including recurrence and death, reveals a study.

ILD ups risks of pneumonitis, mortality in patients taking ICIs

14 Apr 2026

Maternal physical discipline tied to kids’ externalizing problems

14 Apr 2026 by

A Singapore study shows an association between maternal physical discipline and children’s externalizing problems, such as aggressive, delinquent, or hyperactive behaviours.

Maternal physical discipline tied to kids’ externalizing problems

14 Apr 2026

Adjunctive soticlestat minimally beneficial in Lennox–Gastaut syndrome

14 Apr 2026

Use of the cholesterol 24-hydroxylase inhibitor soticlestat as adjunctive therapy in patients with Lennox–Gastaut syndrome (LGS) falls short of reducing the frequency of major motor drop (MMD) seizures, according to the results of the phase III SKYWAY trial.

Adjunctive soticlestat minimally beneficial in Lennox–Gastaut syndrome

14 Apr 2026

[Infographics] Slow down lung function decline in CTD-ILD with nintedanib

14 Apr 2026

Nintedanib is the only antifibrotic approved in Hong Kong for progressive pulmonary fibrosis and systemic sclerosis–associated interstitial lung disease (ILD). Read further on how nintedanib slows lung function decline in connective tissue disease–associated ILD (CTD-ILD), as well as ERS/EULAR 2025 guideline recommendations on screening, diagnosis, monitoring, and treatment of CTD-ILD.

[Infographics] Slow down lung function decline in CTD-ILD with nintedanib

14 Apr 2026

[Infographics] 2026 ASA Practice Guideline: Fascial plane blocks as essential components of perioperative pain management

14 Apr 2026

The 2026 ASA Practice Guideline provides strong recommendations with moderate-strength evidence for FPBs as essential components of perioperative pain management across open cardiothoracic, abdominal, retroperitoneal, pelvic surgeries, mastectomy, and minimally invasive abdominal procedures.

[Infographics] 2026 ASA Practice Guideline: Fascial plane blocks as essential components of perioperative pain management

14 Apr 2026

Can prednisolone be used in place of hydrocortisone in adrenal insufficiency?

13 Apr 2026 by

The use of once-daily, low-dose prednisolone for glucocorticoid replacement in adrenal insufficiency yields substantial improvements in bone turnover and cardiometabolic health markers compared with multiple-dose hydrocortisone, according to the results of a crossover randomized clinical trial.

Can prednisolone be used in place of hydrocortisone in adrenal insufficiency?

13 Apr 2026

ACS patients with SLE require greater healthcare use

13 Apr 2026

Systemic lupus erythematosus (SLE) patients with acute coronary syndrome (ACS) need a longer hospital stay and accrue higher charges, resulting in higher healthcare utilization, reports a study.

ACS patients with SLE require greater healthcare use

13 Apr 2026

More aggressive LDL-C reduction improves cardiac outcomes in ASCVD patients

13 Apr 2026 by

An intensive targeting of low-density lipoprotein cholesterol (LDL-C) level (<55 mg/dL) reduces the risk of cardiovascular events at 3 years in patients with atherosclerotic cardiovascular disease (ASCVD) when compared with conventional targeting (<70 mg/dL), results of the Ez-PAVE trial have shown.

More aggressive LDL-C reduction improves cardiac outcomes in ASCVD patients

13 Apr 2026

Early onset, recurrent illness tied to DADA2 disease damage

13 Apr 2026

In patients with deficiency of adenosine deaminase 2 (DADA2) vasculitis, early age of onset and periodic illness are associated with disease-related damage, but prompt initiation of a tumour necrosis factor inhibitor (TNFi) may prevent complications and severe progression, suggests a study.

Early onset, recurrent illness tied to DADA2 disease damage

13 Apr 2026

Novel combination therapies show potential in management of endocrine resistance in HR+/HER2- mBC

13 Apr 2026 by

Biomarker testing where appropriate and novel tailored combination therapies targeting multiple pathways simultaneously may address the high unmet need and optimize treatment outcomes in hormone receptor–positive (HR+)/HER2-negative (HER2-) metastatic breast cancer (mBC) patients who develop resistance or have disease recurrence while on endocrine-based therapy (ET), said Professor Sherko Kümmel of the Interdisciplinary Breast Unit Clinics, Essen-Mitte, Germany, who spoke at the 14^th Asia-Pacific Breast Cancer Summit (APBCS 2026).

Novel combination therapies show potential in management of endocrine resistance in HR+/HER2- mBC

13 Apr 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

ILD ups risks of pneumonitis, mortality in patients taking ICIs

ILD ups risks of pneumonitis, mortality in patients taking ICIs

Maternal physical discipline tied to kids’ externalizing problems

Maternal physical discipline tied to kids’ externalizing problems

Adjunctive soticlestat minimally beneficial in Lennox–Gastaut syndrome

Adjunctive soticlestat minimally beneficial in Lennox–Gastaut syndrome

[Infographics] Slow down lung function decline in CTD-ILD with nintedanib

[Infographics] Slow down lung function decline in CTD-ILD with nintedanib

[Infographics] 2026 ASA Practice Guideline: Fascial plane blocks as essential components of perioperative pain management

[Infographics] 2026 ASA Practice Guideline: Fascial plane blocks as essential components of perioperative pain management

Can prednisolone be used in place of hydrocortisone in adrenal insufficiency?

Can prednisolone be used in place of hydrocortisone in adrenal insufficiency?

ACS patients with SLE require greater healthcare use

ACS patients with SLE require greater healthcare use

More aggressive LDL-C reduction improves cardiac outcomes in ASCVD patients

More aggressive LDL-C reduction improves cardiac outcomes in ASCVD patients

Early onset, recurrent illness tied to DADA2 disease damage

Early onset, recurrent illness tied to DADA2 disease damage

Novel combination therapies show potential in management of endocrine resistance in HR+/HER2- mBC

Novel combination therapies show potential in management of endocrine resistance in HR+/HER2- mBC